Geistlich Pharma North America, Inc.
Jamie Bratton has a diverse work experience in marketing and business development. Currently, they hold the position of Vice President, Marketing at Geistlich Pharma North America, Inc. They joined in August 2023. Prior to that, Jamie served as Senior Manager, Marketing at the same company starting from July 2022.
Before joining Geistlich Pharma, Jamie worked at Innovative Benefit Planning, LLC. They held the roles of Vice President, Marketing & Engagement from September 2021 to July 2022, and Director, Marketing from August 2018 to September 2021. In these roles, Jamie was responsible for strategic and tactical communication plans, expanding partnerships, and positioning the company as an employer of choice.
Earlier in their career, Jamie worked at Bratton Estate & Elder Care Attorneys as the Director of Marketing and Business Development from August 2011 to May 2018. They provided high-level business development, marketing strategies, and cultivated strong relationships with customers.
Jamie began their career at DentalEZ Group, where they served as a Marketing Communications Manager from July 2008 to August 2011 and as a Merchandising and Event Manager from June 2003 to July 2008. In these roles, they focused on revenue growth, brand management, and creating marketing strategies.
Overall, Jamie Bratton has a robust background in marketing and business development, with experience in strategic planning, brand management, and building strong customer relationships.
Jamie Bratton earned a Bachelor's degree in Marketing from West Chester University of Pennsylvania between 1999 and 2003.
Geistlich Pharma North America, Inc.
Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root, Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide and is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. Geistlich continues to lead oral regeneration based upon our history of quality, scientific collaboration, and manufacturing excellence. Every Geistlich biomaterial is intentionally designed for a specific application and carefully engineered to preserve its natural structures. Today, our full product portfolio of Bone Substitutes, Membranes, and Matrices increases clinical flexibility and expands treatment options in a variety of therapeutic areas. Geistlich Bio-Oss®: Derived from bovine bone and preserved through a unique, patented process, making it highly similar to human bone. Geistlich Bio-Oss® remains the essential choice among an expanding range of therapeutic areas through its unique properties and reliable clinical outcomes. Geistlich Bio-Gide®: A unique bilayer collagen membrane designed to ensure optimal regenerative healing of bone and soft tissue. It provides excellent wound stability and graft containment with optimal protection for bone regeneration. Geistlich Mucograft®: A collagen matrix designed for gain of keratinized tissue and recession coverage where open healing is required. Geistlich Fibro-Gide®: The first volume-stable collagen matrix designed for soft-tissue augmentation around natural teeth and implants as a submerged scaffold where an increase in soft-tissue thickness is clinically desired.